Navigation Links
Drug dilemma confronts users of painkillers

The Food and Drug Administration announced that Vioxx - Merck's blockbuster painkiller, would include new information on its label. The FDA said that Merck can claim that Vioxx has fewer gastrointestinal complications// than one older non-steroidal anti-inflammatory drug, naproxen. But the FDA also decided that the Vioxx label must mention that it might be linked to an increased risk of heart attack or high blood pressure.

Manufacturer Merck & Company got good news, too: Vioxx can advertise that it's gentler to the stomach than an older competitor and that it relieves the pain of rheumatoid arthritis in addition to the more common osteoarthritis. Vioxx and another popular competitor, Celebrex, work differently than older, cheaper painkillers known to cause stomach ulcers.

Merck had fought for over a year to be allowed to say Vioxx is gentler to the stomach. Finally, the FDA agreed that an 8,000-patient study found Vioxx users had half the risk of ulcers as users of the older naproxen. The same study found Vioxx users had twice the risk of heart attacks or other cardiovascular side effects than naproxen patients.

Merck argued that Vioxx isn't bad, but that naproxen offered the added benefit of thinning the blood a little, which Vioxx doesn't do. Studies also show Vioxx can increase the risk of high blood pressure, and that people who use higher-than-recommended doses are more at risk for certain side effects.
'"/>




Page: 1

Related medicine news :

1. A ray of hope in Angioplasty dilemma
2. Safeguarding anti-inflammatory users from ulcers
3. Personality profiles of gamblers and substance abusers are similar
4. Women complain Viagra users want too much sex
5. Morphine Withdrawal Complicates Hepatitis C Infection in Drug Abusers
6. Children Of Alcoholics Tend to Become Drug Abusers In Adulthood
7. UN Warns of HIV epidemic among Asia-Pacific drug users
8. Lack of treatment for cocaine users
9. Reinfection with Hepatitis C Stopped in drug users
10. Calcitriol [Vitamin D] with combination of painkillers for cancer treatment
11. Codeine-based painkillers to be used cautiously
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... , ... June 28, 2017 , ... ... is pleased to announce that a two year study conducted by the University ... Creek zeolite was successful in remediating potash brine-impacted groundwater. As a part of ...
(Date:6/28/2017)... VA (PRWEB) , ... June 28, 2017 , ... ... protection assistance and financial consultations to communities in northern Virginia and DC, is ... to help provide for patients with Alzheimer’s and other disorders that lead to ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly 70 percent of ... released today by the American Society for Dermatologic Surgery (ASDS). , ... of consumers considering a cosmetic medical procedure has doubled since 2013. , “Cosmetic ...
(Date:6/27/2017)... ... June 27, 2017 , ... Salucro, the ... the health care industry’s hospitals and provider groups, has announced that it will ... customers. Parasail Health is a San Francisco health-finance startup that has launched a ...
(Date:6/27/2017)... ... ... From June 20-22, EarQ and Widex held an exclusive training ... EarQ is headquartered. , Together, the organizations educate hearing care professionals on how ... the latest in hearing technology. At the event, EarQ members got an in-depth ...
Breaking Medicine News(10 mins):
(Date:6/5/2017)... , June 5, 2017 Kohll,s Pharmacy ... the United States . The Raizer is ... a fallen person up to an almost-standing position ... and operated by one assistant and does not ... is simple enough that a child can operate it, ...
(Date:6/1/2017)... 2017 Nutriceutical Holdings (NH), parent company of ... and KD Pharma Group have decided to join forces ... Pharma Group. KD Pharma Group will become the largest ... the entire company. "We believe we have ... to growing the NH companies by providing us with ...
(Date:5/30/2017)... May 30, 2017 Therapix Biosciences Ltd. (Nasdaq: ... in the development of cannabinoid-based drugs, today announced ... overview at three upcoming scientific and investor conferences ... Micro Invitational: ... Date:                     Wednesday, ...
Breaking Medicine Technology: